Keywords: titan, ph, iii, probuphine, enrolls, ahead, schedule

Titan's Ph III Probuphine enrolls ahead of schedule

Article | 10 December 2007

Print This

Titan Pharmaceuticals of the USA has announced the early completion of enrollment in a Phase III clinical study of Probuphine ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in